Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Depending on the exchange, the stock ticker may vary. For instance, on exchange Beximco Pharmaceuticals stocks are traded under the ticker BXMPY.
What were Beximco Pharmaceuticals earnings last quarter?▼
BXMPY earnings for the last quarter are 0.03 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Beximco Pharmaceuticals revenue for the last year?▼
Beximco Pharmaceuticals revenue for the last year amounts to 88.48B USD.
What is Beximco Pharmaceuticals net income for the last year?▼
BXMPY net income for the last year is 11.66B USD.
Does Beximco Pharmaceuticals pay dividends?▼
Yes, BXMPY dividends are paid annual. The last dividend per share was 0.03 USD. As of today, Dividend Yield (FWD)% is 0%.
When did Beximco Pharmaceuticals complete a stock split?▼
The last stock split for Beximco Pharmaceuticals was on November 23, 2020 with a ratio of 1.1:1.